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Abstract
While identification and isolation of adult stem cells have potentially important implications, recent reports regarding
dedifferentiation/reprogramming from differentiated cells have provided another clue to gain insight into source of tissue
stem/progenitor cells. In this study, we developed a novel culture system to obtain dedifferentiated progenitor cells from
normal human thyroid tissues. After enzymatic digestion, primary thyrocytes, expressing thyroglobulin, vimentin and
cytokeratin-18, were cultured in a serum-free medium called SAGM. Although the vast majority of cells died, a small
proportion (,0.5%) survived and proliferated. During initial cell expansion, thyroglobulin/cytokeratin-18 expression was
gradually declined in the proliferating cells. Moreover, sorted cells expressing thyroid peroxidase gave rise to proliferating
clones in SAGM. These data suggest that those cells are derived from thyroid follicular cells or at least thyroid-committed
cells. The SAGM-grown cells did not express any thyroid-specific genes. However, after four-week incubation with FBS and
TSH, cytokeratin-18, thyroglobulin, TSH receptor, PAX8 and TTF1 expressions re-emerged. Moreover, surprisingly, the cells
were capable of differentiating into neuronal or adipogenic lineage depending on differentiating conditions. In summary,
we have developed a novel system to generate multilineage progenitor cells from normal human thyroid tissues. This seems
to be achieved by dedifferentiation of thyroid follicular cells. The presently described culture system may be useful for
regenerative medicine, but the primary importance will be as a tool to elucidate the mechanisms of thyroid diseases.
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Introduction
Adult stem cells are rare, premature cells capable of self-renewal
and generating distinct differentiated cell types within a tissue.
There is no doubt that identification and isolation of stem cells
have potentially important implications not only for regenerative
medicine but for understanding of pathogenesis of a variety of
diseases.
The existence of stem cells in adult human thyroid tissue has
been suggested by several studies. Based on immunohistochemical
analyses, two groups proposed that p63-positive cells residing in
solid cell nests may be undifferentiated stem cells and undergo
follicular maturation [1,2,3,4]. Thomas et al. found that a small
subset of cells in nodular goiters express a stem cell marker Oct-4
and endodermal markers GATA-4 and HNF4a using RT-PCR,
immunohistochemistry and flow cytometry; however, no function-
al characterization was performed [5].
The subsequent work by the same group (Lan et al.) reported
that possible stem cells were isolated from nodular goiters using a
sphere formation approach in a serum-free medium containing
epidermal growth factor (EGF) and basic fibroblast growth factor
(bFGF), and some functional studies were performed [6]. This
method has been frequently used to isolate stem cells from several
other tissues. The obtained sphere cells did not express thyroid
specific genes such as thyroglobulin (TG) and TSH receptor (TSH-R),
but their expressions emerged in monolayer culture stimulated by
serum and TSH. However, the growth potential of the cells was
very limited: the proliferation stopped after 4–5 days of culture.
More recently, Fierabracci et al. have also reported the
identification of stem/progenitor cells in normal human thyroid
tissues [7]. They also used similar approach with serum-free/
EGF/bFGF medium and sphere formation. The isolated cells
were probably not fully undifferentiated or not homogeneous,
since TG or thyroid peroxidase (TPO) expression was in part
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structure in collagen gel and produced T4. Surprisingly, some
isolated cells underwent multilineage differentiation into neuro-
genic and adipogenic lineages.
So far, two above-mentioned studies described isolation and
functional characterization of possible stem cells from human
thyroid tissues (including goiters). However, there are still some
uncertainties as for origin and homogeneity of the cells. In
addition, Lan et al. used cells released by enzymatic digestion,
whereas Fierabracci et al. used residual thyroid fragments,
presumably containing cells tightly bound to collagen fibers,
regardless of using very similar medium. Therefore, the isolated
cells by Lan et al. may be different from those by Fierabracci et al.
We tried both methods but could not reproduce the sphere
formation in our hands (unpublished data). Thus, the origin and
procedure of isolation of thyroid stem cells still remain obscure.
Recent reports have provided another clue to gain insight into
source of primitive stem/progenitor cells. In 2007, induced
pluripotent stem (iPS) cells were established from adult human
fibroblasts by direct reprogramming with defined factors [8].
Recently, not only reprogramming (generating pluripotent stem
cells) but also generating tissue stem/progenitor cells (i.e.
dedifferentiation or partial reprogramming) has also been
reported. Mani et al. have demonstrated that differentiated
mammary epithelial cells can be converted into mammary tissue
stem cells by introducing genes related to epithelial-mesenchymal
transition (EMT) [9]. Moreover, cancer stem cells (tumor-initiating
cells) have also been generated from cancer cells [10] or even from
normal epithelial cells [11]. These reports suggest that tissue stem/
progenitor cells could be generated from mature and differentiated
cells.
In the present study, we present a novel culture system in which
progenitor cells can be emerged and propagated from normal
human thyroid follicular cells by dedifferentiation. We also
demonstrate that the cells possess multilineage differentiation
potential.
Materials and Methods
Cell culture and reagents
We used anaplastic thyroid carcinoma cell line: FRO; papillary
thyroid carcinoma cell lines: TPC-1 and KTC-1; follicular thyroid
carcinoma cell line: WRO. All these cells were of human origin.
FRO and WRO were kindly provided by Dr G. Juillard
(University of California, Los Angeles, CA). TPC-1 and KTC-1
were kindly provided by Dr Sato (Kanazawa University,
Kanazawa, Japan) and Dr Kurebayashi (Kawasaki Medical
School, Kurashiki, Japan), respectively. All the cells were
maintained in RPMI-1640 medium supplemented with 5% fetal
bovine serum (FBS; Invitrogen, Carlsbad, CA) and penicillin/
streptomycin (Sigma, St. Louis, MO) at 37uC in a humidified
atmosphere with 5% CO2. Primary human thyroid cells (PT) were
isolated from thyroid tissues obtained during subtotal thyroidec-
tomy in patients with Graves’ disease as described previously [12]
and cultured overnight in DMEM:F12 medium (1:2) supplement-
ed with 3.3% FBS and penicillin/streptomycin (PT medium). All
experiments were performed after obtaining approval by the
Ethical Committee of Nagasaki University Graduate School of
Biomedical Sciences. Written informed consent was obtained from
each individual. SAGM was purchased from Lonza (Basel,
Switzerland). For neurogenic and adipogenic differentiation,
Human Neural Stem Cell Functional Identification Kit (R&D
Systems, Minneapolis, MN) and StemPro Adipogenesis Differen-
tiation Kit (Invitrogen) were used, respectively. Bovine TSH
(bTSH) was purchased from Sigma. Oil-red-O staining was
performed using Lipid Assay kit (Primary Cell Co., Sapporo,
Japan).
Immunofluorescence
Cells cultured on coverslips were fixed and immunolabeled as
previously described [13]. The following primary antibodies were
used: anti-phosphorylated H2AX (Ser139) (mouse clone JBW301,
Millipore, Billerica, MA), anti-cytokeratin-18 (Clone DC 10, Dako
Cytomation, Glostrup, Denmark), anti-vimentin (Clone V9, Dako
Cytomation), anti-STRO-1 (Clone STRO-1, R&D Systems) and
anti-TG (mouse clone B34.1, GeneTex, Irvine, CA). Anti-b-III-
tubulin antibody was included in Human Neural Stem Cell
Functional Identification Kit (R&D Systems). After labeling with
secondary antibodies conjugated with Alexa 488 or 594 (Invitro-
gen), images were acquired using a fluorescence microscopy
DM6000B (Leica Microsystems, Tokyo, Japan).
Senescence-associated b-galactosidase (SA-b-gal)
staining
SA-b-gal staining was carried out as described by Dimri et al.
[14]. Briefly, cells were fixed with 2% paraformaldehyde solution
containing 0.2% glutaraldehyde for 5 min at room temperature.
After fixation, the cells were then incubated with stain solution
(40 mM citric acid/sodium phosphate, pH 6.0, 5 mM potassium
ferrocyanide, 5 mM potassium ferricyanide, 150 mM NaCl, and
2 mM MgCl2) containing 1 mg/ml X-gal at 37uC for overnight.
Fluorescence-activated cell sorting
Isolated PT were cultured overnight in PT medium supple-
mented with 10 mIU/ml bTSH. On the next day, PT were
collected and incubated with anti-STRO-1 or anti-TPO (Clone
MoAb47, Dako Cytomation) antibody. After labeling with
secondary antibody conjugated with Alexa 488 and 7-AAD (BD
Biosciences, Franklin Lakes, NJ), the cells were analyzed and
sorted using a FACS Vantage SE (BD Biosciences).
Real-time RT-PCR
Total RNA was extracted using ISOGEN reagent (Nippon
gene, Tokyo, Japan) and reverse transcribed using SuperScript III
First-Strand Synthesis SuperMix (Invitrogen) with random
hexamers. The following PCR amplifications were performed
using QuantiTect SYBR Green RT-PCR kit (Qiagen, Valencia,
CA) for TTF1 and SYBR Premix Ex Taq Perfect Real Time kit
(TaKaRa Bio, Ohtsu, Japan) for other genes in a Thermal Cycler
Dice Real Time System (TaKaRa Bio). The cycle threshold value,
which was determined using second derivative, was used to
calculate the normalized expression of the indicated genes using
Q-Gene software [15], using ribosomal RNA 18S as a reference.
The following primer pairs were used: 18S, 59-GTAACCCGTT-
GAACCCCATT-39 and 59-CCATCCAATCGGTAGTAGCG-
39; TG, 59-CTGGTGTGTCATGGACAGCGGAGAA-39 and
59-CCCGAGATTGTCTCACACAGGAT-39; TSH-R 59-CTA-
TAGATGTGACTCTGCAGCAGCT-39 and 59-GAGGGCAT-
CAGGGTCTATGTAAGT-39; PAX8 59-CCCCCTACTCCT-
CCTACAGC-39 and 59-ACTGTCCCCATGGCAACTAC-39;
TTF1 59-CCATGAGGAACAGCGCCTC-39 and 59-CTCACG
TCCCCCAGCGA-39.
Microarray analysis
Total RNAs were extracted from PT from three different
samples (PT0808, PT0811 and PT0812) on the next day of initial
plating and corresponding SAGM-grown lines at two weeks after
Multilineage Progenitor Cells from Thyrocytes
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Affymetrix GeneChip Human Genome U133 Plus 2.0 microarray
analysis service (Bio Matrix Research, Nagareyama, Japan). The
array contained 54,675 probes for mRNAs. GeneSpring Software
(Agilent Technologies, Santa Clara, CA) was used for data
analyses. The data were deposited in NCBI GEO site (accession
number: GSE24553).
Results
Isolation of proliferative cells from normal human thyroid
tissues
In an attempt to isolate primitive human thyroid epithelial cells,
we tried several commercially available media containing growth
factors but not serum which is generally thought to enforce
differentiation program. Those were basically developed for
growing human primary cells or tissue stem cells. Among them,
we found that SAGM was the most suitable for our purpose, which
was developed for growing human primary small airway epithelial
cells.
After enzymatic digestion of thyroid tissues, primary thyrocytes
(PT) were plated in PT medium containing FBS which facilitated
attachment of the cells. On the next day, the PT medium was
replaced by SAGM (Figure 1A; a). Within 7–10 days culture, the
vast majority of the cells died (Figure 1A; b). This was probably
due to induction of apoptosis, which was confirmed by nuclear
fragmentation and c-H2AX staining (massive DNA double strand
breaks, Figure 1A; c) [16]. By contrast, clonal expansion of a small
proportion became evident by 7–10 days culture, and they grew
continuously (Figure 1A; d–f). These cells showed mesenchymal
cell-like morphology (Figure 1A; e, f). Doubling time of the cells
was approximately 24–36 hours during first 1–2 months. Time-
lapse analysis looking at cell cycle length demonstrated that some
of them showed asymmetric division in culture (Figure S1). The
SAGM-grown cells had 46 chromosomes with no apparent gross
rearrangement by Giemsa staining. Growth rate of the cells
gradually declined and eventually became flat by approximately
3–4 months. At this point, the cells were positive for SA-b-gal
staining, indicating that they became senescent (Figure 1B).
We used more than 10 tissues from Graves’ patients and
successfully obtained proliferative cells from all of them. On
average, approximately 40–50 cells were estimated to have
clonogenic potential among 10,000 PT (Figure 1C).
Characteristic expression of intermediate filaments in
thyroid cells
To characterize the SAGM-grown cells, we investigated
expression of intermediate filaments because their expression
pattern depends on type of cell lineage. First of all, we checked the
expression in PT. As shown in Figure 2A, cytokeratin-18, generally
found in single layer epithelial tissues, was abundantly expressed in
PT. Expression of vimentin, which is usually found in non-
epithelial type of cells such as fibroblasts and endothelial cells, was
also observed in PT (Figure 2A). TG expression was confirmed,
ensuring that these cells are bona fide thyroid follicular cells
(Figure 2A). Next, we checked the cytokeratin-18 and vimentin
expression in thyroid cancer cell lines. FRO, TPC-1 and WRO
expressed both filaments as well as PT (data not shown). These
data suggest that both cytokeratin-18 and vimentin are expressed
in normal thyroid and thyroid cancer cells. We then examined the
SAGM-grown cells and found that only vimentin but not
cytokeratin-18 was expressed in these cells (Figure 2B).
Origin of the SAGM-grown cells
The above observations prompted us to explore the origin of the
SAGM-grown cells because all examined thyroid cells even
anaplastic cancer cell line expressed cytokeratin-18. Since
vimentin is used as a marker of mesenchymal cells, we next used
a mesenchymal stem cell marker STRO-1. Three days after
plating (no dead cells at this time point), a small number of cells
were positive for STRO-1, and these cells were negative for
cytokeratin-18 (Figure 2C, arrowheads). We found that all
cytokeratin-18-negative cells were STRO-1/vimentin-positive.
This was confirmed by analyzing about 4,500 cells by fluorescence
microscopy (Table 1). Vimentin was expressed in all attached cells
(Table 1). These data indicate that there were two types of
Figure 1. Isolation of proliferative cells from normal human
thyroid tissue. A, (a) PT on the next day of plating. (b) A cluster of
dead cells within 7–10 days. (c) c-H2AX staining of dead cells. (d–f)
Expansion of cells after 7–10 days. B, After cultured for three months,
the cells showed positive for SA-b-gal staining. C, Clonogenic ability of
the primary cells incubated with SAGM. Each bar indicates the mean
and SD of three dishes.
doi:10.1371/journal.pone.0019354.g001
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PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e19354Figure 2. Origin of the SAGM-grown cells. A, On the next day after plating, PT were fixed and followed by immunofluorescence staining using
following primary antibodies: cytokeratin-18 (red), vimentin (green) and TG (green). B, After grown for three weeks, the SAGM-grown cells were fixed
and stained for cytokeratin-18 (red) and vimentin (green). C and E, Cells were fixed and then stained for STRO-1 (green) and cytokeratin-18 (red) on
indicated days after plating. Arrowheads indicate STRO-1-positive cells. D, Five days after plating, cells were fixed and stained for cytokeratin-18 (red)
and vimentin (green). At the center of each image, cell cluster just starting expansion is shown. F, At indicated time points, total RNA was extracted
and then subjected to qRT-PCR for TG. Each bar indicates the mean and SD of the data collected in triplicate. 2 w P1: two weeks after first passage
(the cells were subcultured at three weeks). RNAs from KTC-1 and Hela cells were also used as controls. Similar results were obtained in three different
samples. G, On the next day after plating, PT were stained with anti-STRO-1 or anti-TPO antibody and subjected to FACS. Each box means sorting gate
for STRO-1-positive or TPO
hi cells.
doi:10.1371/journal.pone.0019354.g002
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vimentin double-positive cells and vimentin/STRO-1 double-
positive cells. By contrast, the SAGM-grown cells (20 days after
plating) did not express STRO-1 (Figure 2C).
Next, we carefully investigated the process of the beginning of
proliferation by fixing cells every two days. We found clusters with
5–10 cells just starting expansion 5–7 days after plating
(Figure 2D). As expected, vimentin was expressed in these cells,
while cytokeratin-18 was only weakly expressed in the same cells
(Figure 2D), suggesting that the proliferating cells were losing
cytokeratin-18 expression. In contrast, at the same time point,
vimentin/STRO-1-positive and cytokeratin-18-negative cells did
not proliferate at all (Figure 2E, arrowheads; Table S1).
We also measured relative expression of TG mRNA by real-time
quantitative RT-PCR (qRT-PCR). At one week, TG expression
was due to residual differentiated thyroid follicular cells (Figure 2F).
The amount of TG mRNA gradually decreased; however, the
SAGM-grown cells after three-week culture still expressed low
level of TG mRNA, which was still higher than that in KTC-1 cells
(Figure 2F). KTC-1 cells show relatively higher PAX-8 and TTF-1
transcripts among thyroid cancer cell lines [17].
To further confirm the origin of the proliferating cells, we next
performed selective cell culture in SAGM after fluorescence-
activated cell sorting (FACS) using anti-STRO-1 (for sorting
STRO-1-positive cells) and anti-TPO (for sorting thyroid follicular
cells) antibodies (Figure 2G). The percentages of TPO-positive
cells were 70–90% depending on samples, and we sorted top 40%
(TPO
hi cells) for subsequent cultures. As expected, STRO-1-
positive (approximately 1%) cells did not grow at all in SAGM,
whereas TPO
hi cells gave rise to proliferating colonies (Table S2).
Taken together, these results suggest that the SAGM-grown
cells were derived from thyroid follicular cells or at least thyroid-
committed cells.
Differentiation of the SAGM-grown cells
The SAGM-grown cells were incubated with PT medium
supplemented with 10 mIU/ml bTSH, and the expression of
cytokeratin-18 and TG was examined at different time points. The
growth of the cells stopped in this medium. As shown in Figure 3A,
the expression of cytokeratin-18 was gradually increased
(Figure 3A). TG expression was also evident after 30 days
stimulation (Figure 3A). We also checked mRNA expression of
TSH-R, TG, PAX8 and TTF-1 by qRT-PCR. Although the levels
of induction varied depending on the samples, all of the messages
were gradually increased (Figure 3B). Interestingly, serum
stimulation alone (without bTSH) up-regulated TSH-R expression,
whereas TG induction needed both serum and bTSH stimulation
(Figure 3B). These data indicate that the SAGM-grown cells were
differentiated into thyroid follicular lineage. We next explored the
differentiation potential of the cells into other lineages. Surpris-
ingly, after incubation with the neurogenic differentiating medium
for four weeks, the SAGM-grown cells expressed b-III-tubulin,
which is a microtubule element of the tubulin family found almost
exclusively in neurons (Figure 3C). Moreover, after four-week-
treatment with the adipogenic differentiating medium, many lipid
droplets were formed, and they were all positive for oil-red-O
staining (Figure 3C). We measured the proportion of differenti-
ation marker-positive cells in each differentiating condition. In
thyroid differentiation, most of cells (.90%) were positive for TG,
while b-III-tubulin-positive and oil-red-O-positive cells varied (48–
87%) presumably depending on conditions (Table 2). These data
suggest that the SAGM-grown cells have multipotent (at least
dipotent) differentiation potential.
Gene expression profile of the SAGM-grown cells
To perform a comprehensive analysis of differential gene
expressions between PT and SAGM-grown cells, we used
oligonucleotide-based DNA microarrays, GeneChip Human
Genome U133 Plus 2.0 array (Affmetrix). This array system
utilizes flag score (present, marginal and absent) calculated by the
difference in signals between perfect match (PM) and mismatch
(MM) probes. Probes with absent call likely represent undetectably
low expression (but not always), and therefore, the fold-change is
not accurate. Of 54,675 probe-sets, 27,535, 26,800 and 26,929
were scored as ‘‘present call’’ (neither marginal nor absent) in both
PT and SAGM-grown cells of PT0808, PT0811 and PT0812,
respectively. The tree view of hierarchical clustering using probes
with present call indicated distinct patterns in gene expressions
between PT and SAGM-grown cells (Figure 4A).
We next checked the fold-change of interested genes (Table 3).
Probes with absent call in either PT or SAGM sample are also
included because it is still possible to estimate the significant
change even though its fold-change is not reliable. Stem cell
marker ABCG2, Oct-4 and CD133 were not expressed in the
SAGM-grown cells. Thyroid-specific genes such as TG, TSH-R,
PAX8, TTF1 and TPO seemed to be highly suppressed, which was
validated by qRT-PCR (Figure 4B). Among other tissue stem cell
markers, CD106, CD105 and CD90, which are marker for
mesenchymal and/or hematopoietic stem cell, were up-regulated.
E-cadherin, whose loss is correlated with induction of EMT, was
highly down-regulated.
Next, we selected 663 genes that were significantly (t-test,
p,0.05) and .2.0-fold increased in all the SAGM-grown cells
compared to corresponding PT. Likewise, 649 genes were selected
as down-regulated genes (,0.5-fold). Probes with absent call in
either PT or SAGM sample are excluded. To get insight into the
biological significance, Gene Ontology (GO) enrichment analysis
was performed to identify specifically regulated biological
processes using the above selected genes. Sixteen and four GO
processes were significantly impacted (p,0.1) in the up- and
down-regulated gene sets, respectively (Table 4). Interestingly,
some particular processes were impacted. Processes related to
embryo implantation, endoplasmic reticulum, sterol/steroid, cell
cycle and oxidoreductase were up-regulated, and those related to
protein binding and cell adhesion were down-regulated (Table 4).
Discussion
In the present study, we have developed a novel system to
trigger dedifferentiation of normal human thyroid follicular cells.
We used a commercially available medium which allowed
universal and reproducible procedure. We investigated the origin
Table 1. Expression of lineage-specific markers in primary
thyrocytes.
Cells
Total
count Cyt
+ Vim
+ Cyt
+/Vim
+ Vim
+/STRO-1
+
PT-0808 4507 4472 (99.2) 4507 (100) 4472 (99.2) 35 (0.8)
PT-0811 4856 4809 (99.0) 4856 (100) 4472 (99.0) 47 (1.0)
PT-0818 4728 4686 (99.1) 4728 (100) 4686 (99.1) 42 (0.9)
PT-0901 4413 4376 (99.2) 4413 (100) 4376 (99.2) 37 (0.8)
No. of cells (%).
Determined by immunofluorescence.
doi:10.1371/journal.pone.0019354.t001
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PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e19354Figure 3. Differentiation of the SAGM-grown cells. A, The SAGM-grown cells were incubated with PT medium supplemented with bTSH for
indicated times. The cells were then fixed and stained for cytokeratin-18 (red) and TG (green). B, At indicated time points, total RNA was extracted and
subjected to qRT-PCR for indicated gene expressions. Each bar indicates the mean of the data collected in duplicate. C, The SAGM-grown cells were
incubated with neurogenic differentiation medium or adipogenic differentiation medium for four weeks. The cells were fixed and stained for b-III-
tubulin (upper, immunofluorescence) or lipid (middle, oil-red-O staining). Ph: phase contrast image of cells with lipid droplets. The data are
representative of three independent experiments.
doi:10.1371/journal.pone.0019354.g003
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intermediate filaments, cytokeratin-18 and vimentin. In our
system, there were only two types of attached cells in terms of
expression pattern of the above-mentioned markers after initial
plating: cytokeratin-18/vimentin double-positive cells and STRO-
1/vimentin double-positive cells. Thyroid follicular cells coexpress
cytokeratin-18 and vimentin, which is consistent with earlier
studies [18,19,20]. Cytokeratin-18/vimentin-positive cells may
also contain a small number of endothelial cells since several
papers demonstrated expression of cytokeratin in microvascular
endothelial cells in different tissues [21,22,23,24,25]. STRO-1/
vimentin-positive cells are perhaps composed of premature
mesenchymal cells. The SAGM-grown cells were propagated
from thyroid follicular cells (or at least thyroid-committed cells)
because: (1) the SAGM-grown cells were negative for STRO-1; (2)
the cells lost cytokeratin-18 expression during expansion; (3)
STRO-1-positive cells did not proliferate; (4) TG mRNA
expression was also decreased during proliferation but still
detectable after 3–5 weeks; (5) the SAGM-grown cells were
propagated from sorted TPO
hi cells.
Although both cytokeratin-18 and vimentin expressions were
observed even in undifferentiated thyroid cancer cell lines, the
cytokeratin-18 expression was lost in the SAGM-grown cells. All of
thyroid-specific gene expressions were not observed in the cells.
Moreover, the SAGM-grown cells displayed high plasticity:
multilineage differentiation potential into thyrocytes, neuronal
cells and adipocytes. These results suggest that we have
successfully dedifferentiated/converted thyroid follicular cells into
multilineage progenitor cells. However, re-differentiation effects
(expression level of thyroid-specific genes) were modest compared
to PT. We are currently seeking the better method enabling more
efficient differentiation. In addition, these cells do not have
unlimited proliferative capacity: the cells will stop growing until 3–
4 months, due to cellular senescence.
Conversion of differentiated cells into multipotent progenitor or
different lineage has been reported by several groups. Adult
hepatocytes were converted into insulin-producing cells by
transgenes, Pdx-1 and Ngn-3 [26]; retinal pigment epithelium into
retinal neurons by Sox-2 [27]; and interfollicular epidermal basal
keratinocytes into the cells capable of differentiating into neuronal
cells by Oct-4 [28]. The aforementioned studies used exogenous
trangenes, some of which are key transcription factors for
generating iPS cells. To our knowledge, there is only one report
describing conversion from differentiated cells into multilineage
progenitor cells without any gene delivery. Adult intestinal
epithelial cells were dedifferentiated into nestin-positive cells that
have multilineage differentiation capacity into neuronal, pancre-
atic and hepatic lineages [29]. The authors cultured intestinal
epithelial cells on mouse embryonic fibroblasts (feeder layer) in
medium supplemented with leukemia inhibitory factor, EGF and
bFGF. For generating iPS cells, two key transcription factors Klf-4
and Sox-2 could be replaced by chemical compounds [30,31].
Table 2. Percentage of differentiated marker-positive cells in
each differentiating condition.
Cells Tg
+ b-III-tub
+ Oil-red-O
+
PT-0808 96.8 67.1 87.0
PT-0902 93.9 55.0 48.6
% of positive cells.
doi:10.1371/journal.pone.0019354.t002
Figure 4. Microarray analysis of PT and corresponding SAGM-grown cells. A, The tree view of hierarchical clustering. PT: total RNA was
extracted from PT on the next day of plating. SAGM: the SAGM-grown cells were expanded for two weeks and subcultured. On the next day, total
RNA was extracted. The total RNAs were subjected to Affymetrix GeneChip Human Genome U133 Plus 2.0 microarray analysis service. Hierarchical
clustering (by Manhattan distance) was performed using probes with ‘‘present call’’ only. Red columns represent higher expression, and green
indicate lower expression. B, Confirmation of microarray data. Total RNA was subjected to qRT-PCR for indicated genes. Each bar indicates the mean
and SD of the data collected in triplicate.
doi:10.1371/journal.pone.0019354.g004
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These findings suggest that a particular combination of growth
factors/chemicals probably changes transcriptional profiling,
leading to dedifferentiation of thyrocytes.
Microarray analysis revealed that the expression of ABCG2, Oct-
4 and CD133 which have been used to identify stem cells in a
number of tissues, were not up-regulated in the SAGM-grown
cells, suggesting that the cells were a bit far from genuine
pluripotent stem cells. Rather, they seem to be more committed
stem/progenitor cells. In fact, mesenchymal stem cell markers
CD106, CD105 and CD90 but not CD73 were highly up-regulated.
Taken together with down-regulation of E-cadherin, these results
suggest that the SAGM-grown cells acquired properties prior to
cells committed to thyroid epithelial lineage.
GO enrichment analysis was performed and revealed differen-
tially regulated cellular processes. Embryo implantation had the
lowest p value among the up-regulated GO processes. Other up-
regulated processes were endoplasmic reticulum, sterol/steroid/
lipid biosynthesis/metabolic processes, cell cycle and oxidoreduc-
tase activity. These processes are generally related to protein/
membrane synthesis presumably linked to cell proliferation.
Regarding down-regulated GO processes, protein binding and
cell adhesion processes were impacted. The down-regulation of
cytoskeletal protein binding process might reflect to the loss of
Table 3. Fold-change of interested genes (SAGM cells/PT).
PT0808 PT0811 PT0812
Gene Probe PT-flag SAGM-flag fold PT-flag SAGM-flag fold PT-flag SAGM-flag fold
ABCG2 209735_at A A A A A A
Oct4 208286_x_at A A A A A A
CD133 204304_s_at P A 0.00 P A 0.03 P A 0.04
TG 203673_at P A 0.05 P A 0.00 P A 0.19
TSHR 210055_at P A 0.04 P A 0.16 P A 0.04
215442_s_at P P 0.06 P A 0.25 P P 0.20
215443_at P P 0.06 P A 0.02 P A 0.05
237349_at A A A A A A
PAX8 121_at P P 0.06 P P 0.05 P P 0.11
207921_x_at P A 0.19 P A 0.09 P P 0.24
207923_x_at P A 0.06 P A 0.01 P A 0.14
207924_x_at P A 0.14 P A 0.01 P A 0.10
209552_at P P 0.04 P A 0.01 P P 0.03
213917_at P A 0.13 P A 0.02 P A 0.03
214528_s_at P A 0.02 P A 0.02 P A 0.07
221990_at P A 0.12 P A 0.00 P A 0.06
TPO 210342_s_at P A 0.34 P A 0.03 P A 0.62
TTF1 210673_x_at P A 0.01 P A 0.02 P A 0.44
211024_s_at P P 0.04 P P 0.04 P P 0.12
CD106 203868_s_at A P 4.41 P A 1.85 A P 6.61
CD105 201808_s_at A A A A A A
201809_s_at A P 6.67 A P 5.31 P P 2.57
228586_at A A A A A A
CD90 208850_s_at P P 13.59 A P 859.78 A P 76.16
208851_s_at P P 9.70 P P 51.57 M P 47.39
213869_x_at P P 10.58 A P 39.91 A P 23.06
CD73 203939_at P P 0.83 P P 1.27 P P 1.50
227486_at P P 1.22 P P 1.46 P P 1.18
1553994_at P P 0.74 P P 1.19 P P 1.26
1553995_a_at P P 0.70 P P 1.16 P P 1.24
KRT18 201596_x_at P P 0.02 P P 0.02 P P 0.31
Vim 201426_s_at P P 1.37 P P 1.21 P P 1.31
1555938_x_at P P 0.75 P P 1.00 P P 0.46
E-CAD 201130_s_at P A 0.19 P A 0.12 P A 0.25
201131_s_at P P 0.03 P P 0.02 P P 0.25
Flag score; P: present, M: marginal, A: absent.
doi:10.1371/journal.pone.0019354.t003
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process might be a consequence of the loss of epithelial property
and/or polarity. It should be noted that we selected only probes
scored as ‘‘present call’’ in all samples, which allows relatively
accurate comparison of expression levels between samples.
However, this means that genes with very low expression in
either PT or the SAGM-grown cells were probably excluded even
though their difference in expression levels was far greater.
In summary, we have developed a novel system to propagate
multilineage progenitor cells from adult normal human thyroid
tissues. This seems to be achieved by dedifferentiation of thyroid
follicular cells without any gene delivery. Since integration of
transgene(s) may cause unpredictable problem, our system has an
advantage in terms of safety. The presently described culture
system may be useful for regenerative medicine, but the primary
importance will be as a tool to elucidate the progression of thyroid
disease. Moreover, this phenomenon could be induced in vivo
because it can be achieved without introducing foreign genes.
However, as we have not confirmed full functional differentiation
of the cells, further study is necessary for regenerative application.
Supporting Information
Figure S1 Asymmetric division of the SAGM-grown cells. A,
Scheme of cell divisions. Representative data obtained by time-
lapse imaging of cell cycle are shown. ACD: asymmetric cell
division, SCD: symmetric cell division. 6.1% of the cells showed
asymmetric division after first division. Total 198 cells were
analyzed. B, Representative images after asymmetric division.
(TIF)
Table S1 Time-course expression of lineage-specific markers.
(PDF)
Table S2 Colony formation in SAGM after FACS.
(PDF)
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